Device Cardiology/Vascular Diseases

Sensinel Cpm Wearable

Payments companies reported to CMS as associated with Sensinel Cpm Wearable. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$62Kassociated payments (2023-2025)
170clinicians with associated payments
1company reporting

By year

2024 $23K
2025 $40K

Payments reported as associated with Sensinel Cpm Wearable, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Nurse Practitioner $34K
Cardiovascular Disease $17K
Pediatrics $4,675
Gerontology (Nurse Practitioner) $1,625
Advanced Heart Failure and Transplant Cardiology $1,543
Family $742

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sensinel Cpm Wearable

These are the largest totals companies reported as associated with Sensinel Cpm Wearable. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Nancy Sydow N Chelmsford, MA Nurse Practitioner $33,896.63
Marat Fudim Durham, NC Cardiovascular Disease $8,097.65
Celeste Williams Detroit, MI Cardiovascular Disease $7,500.00
Ravi Raheja Winston Salem, NC Pediatrics $4,675.00
Timothy Malinowski Greenville, SC Gerontology (Nurse Practitioner) $1,250.00
Edward Lin New York, NY Advanced Heart Failure and Transplant Cardiology $483.23
Jennifer Fox Flemington, NJ Gerontology (Nurse Practitioner) $299.73
Sirtaz Adatya Santa Clara, CA Cardiovascular Disease $295.15
Sophia Veinoglou Gt Barrington, MA Nurse Practitioner $207.24
Andrew Darlington Fayetteville, GA Advanced Heart Failure and Transplant Cardiology $152.88

Prescribed Sensinel Cpm Wearable?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.